$1.09 Billion is the total value of LANSDOWNE PARTNERS (UK) LLP's 81 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FCX | Sell | FREEPORT-MCMORAN INCcl b | $49,802,530 | -33.7% | 1,335,510 | -28.9% | 4.56% | -45.3% |
| GOLF | Sell | ACUSHNET HLDGS CORP | $49,430,377 | -7.3% | 931,931 | -4.4% | 4.52% | -23.4% |
| ETN | Sell | EATON CORP PLC | $45,136,458 | -33.2% | 211,626 | -37.0% | 4.13% | -44.9% |
| ADI | Sell | ANALOG DEVICES INC | $44,739,873 | -45.8% | 255,525 | -39.7% | 4.09% | -55.3% |
| Sell | SOHO HOUSE & CO INC | $18,114,381 | +23.2% | 2,614,682 | -3.7% | 1.66% | +1.7% | |
| LLY | Sell | ELI LILLY & CO | $17,644,886 | -31.9% | 32,851 | -40.5% | 1.61% | -43.8% |
| Sell | IONQ INC | $10,640,315 | -51.8% | 715,075 | -56.2% | 0.97% | -60.3% | |
| GOLD | Sell | BARRICK GOLD CORP | $7,224,777 | -23.3% | 496,584 | -10.7% | 0.66% | -36.7% |
| SCHW | Sell | SCHWAB CHARLES CORP | $3,843,000 | -22.1% | 70,000 | -19.5% | 0.35% | -35.6% |
| Sell | RIGETTI COMPUTING INC | $268,864 | -64.4% | 202,298 | -68.6% | 0.02% | -70.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DELTA AIR LINES INC DEL | 38 | Q3 2023 | 25.1% |
| EATON CORP PLC | 33 | Q3 2023 | 11.6% |
| TAIWAN SEMICONDUCTOR MFG LTD | 25 | Q3 2023 | 17.9% |
| MANCHESTER UTD PLC NEW | 22 | Q3 2019 | 1.0% |
| SUMMIT THERAPEUTICS PLC | 22 | Q2 2020 | 0.6% |
| AMAZON COM INC | 21 | Q3 2023 | 13.9% |
| JPMORGAN CHASE & CO | 20 | Q1 2019 | 19.9% |
| CITIGROUP INC | 20 | Q4 2020 | 12.2% |
| FIRST SOLAR INC | 20 | Q3 2021 | 4.2% |
| UNITED TECHNOLOGIES CORP | 20 | Q1 2020 | 3.7% |
View LANSDOWNE PARTNERS (UK) LLP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Supernova Partners Acquisition Co II, Ltd. | February 14, 2022 | 2,152,911 | 6.2% |
| Summit Therapeutics plc | June 17, 2020 | 13,664,880 | 4.1% |
| Manchester United plcSold out | February 14, 2020 | 0 | 0.0% |
| CYTOKINETICS INC | January 30, 2018 | 2,647,981 | 4.9% |
| RESPONSE GENETICS INCSold out | February 12, 2016 | 0 | 0.0% |
View LANSDOWNE PARTNERS (UK) LLP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| SC 13G | 2023-02-08 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
View LANSDOWNE PARTNERS (UK) LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.